Questions discussed in this category
At the time of count recovery or do you continue it throughout induction and consolidation?
Do you just use antibiotic prophylaxis if therapy is started prior to meningococcal vaccination?
Does treatment with B-cell depletion and/or negative anti-spike antibody status despite COVID mRNA vaccination influence your decision?
Is there a role for empiric antibiotics if there is history of opportunistic infection?
Is it at neutrophil recovery, at documentation of CR on bone marrow biopsy, or is there a different point in time?
192771925216541185491797017212146521412813902115671055299637526
Papers discussed in this category
The New England journal of medicine, 2007-01-25
Seminars in hematology, 2013-07
Ann Oncol, 2021 Mar 18
Clin Microbiol Infect, 2018 Feb 07
Urology, 1982-09
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009-03
Clin Infect Dis, 2005 Jan 21
Pediatr Transplant, 2014 Sep 08
J Clin Oncol, 2021 Apr 30
Pediatr Infect Dis J, 2014 Nov
Bone Marrow Transplant, 2006 Mar
Journal of medical case reports, 2014 Mar 04
Journal of oncology practice, 2018-09-04
Leukemia & lymphoma, 2022 Mar 15
Hematology. American Society of Hematology. Education Program, 2020 Dec 04